Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Exercise and Ischemia-Activated Pathways in Limb Muscle Angiogenesis and Vascular Regeneration, Vihang A Narkar
Association of Immune-Related Adverse Events With the Outcomes of Immune Checkpoint Inhibitors in Patients With dMMR/Msi-H Metastatic Colorectal Cancer, Vincenzo Nasca, Francesco Barretta, Francesca Corti, et al.
Fast Inference of Genetic Recombination Rates In Biobank Scale Data, Ardalan Naseri, William Yue, Shaojie Zhang, et al.
Quality Assurance Assessment of Intra-Acquisition Diffusion-Weighted and T2-Weighted Magnetic Resonance Imaging Registration and Contour Propagation for Head and Neck Cancer Radiotherapy, Mohamed A Naser, Kareem A Wahid, Sara Ahmed, et al.
Epigenomic Charting and Functional Annotation of Risk Loci in Renal Cell CarcinomaEpigenomic Charting and Functional Annotation of Risk Loci in Renal Cell Carcinoma, Amin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.
Case Report: Responses to the Combination of Gemcitabine With Sirolimus in Two Patients With TSC-Mutated Sarcomas, Elise F Nassif, Cissimol P Joseph, Rossana Lazcano, et al.
Oncolytic DNX-2401 Virotherapy Plus Pembrolizumab in Recurrent Glioblastoma: A Phase 1/2 Trial, Farshad Nassiri, Vikas Patil, Leeor S Yefet, et al.
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers, Juliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
AIBP Regulates TRPV1 Activation in Chemotherapy-Induced Peripheral Neuropathy by Controlling Lipid Raft Dynamics and Proximity to TLR4 in Dorsal Root Ganglion Neurons, Juliana M Navia-Pelaez, Julia Borges Paes Lemes, Leonardo Gonzalez, et al.
AIBP Regulates TRPV1 Activation in Chemotherapy-Induced Peripheral Neuropathy by Controlling Lipid Raft Dynamics and Proximity to TLR4 in Dorsal Root Ganglion Neurons, Juliana M Navia-Pelaez, Julia Borges Paes Lemes, Leonardo Gonzalez, et al.
Three-Dimensional Printing Bioceramic Scaffolds Using Direct-Ink-Writing for Craniomaxillofacial Bone Regeneration, Vasudev Vivekanand Nayak, Blaire V Slavin, Edmara T P Bergamo, et al.
Effect of Nanoparticle Loading and Magnetic Field Application on the Thermodynamic, Optical, and Rheological Behavior of Thermoresponsive Polymer Solutions, Christopher A P Neal, Grace V Kresge, Michelle C Quan, et al.
Tuning the Thermodynamic, Optical, and Rheological Properties of Thermoresponsive Polymer Solutions via Silica Nanoparticle Shape and Concentration, Christopher A P Neal, Valeria León, Michelle C Quan, et al.
Hazard Testing To Reduce Risk in the Development of Automated Planning Tools, Kelly A Nealon, Raphael J Douglas, Eun Young Han, et al.
Care After Premenopausal Risk-Reducing Salpingo-Oophorectomy in High-Risk Women: Scoping Review and International Consensus Recommendations, Denise R Nebgen, Susan M Domchek, Joanne Kotsopoulos, et al.
Five-Year Follow-Up of Zuma-1 Supports the Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-cell Lymphoma, Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, et al.
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC, Marcelo V Negrao, Haniel A Araujo, Giuseppe Lamberti, et al.
Vidutolimod in Combination With Atezolizumab With and Without Radiation Therapy in Patients With Programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Blockade-Resistant Advanced NSCLC, Marcelo V Negrao, Vassiliki A Papadimitrakopoulou, Andrew C Price, et al.
On Target Methods to Induce Abscopal Phenomenon for Off-Target Effects: From Happenstance to Happenings, Blessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, et al.
The Abscopal Effect in Patients With Cancer Receiving Immunotherapy, Blessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, et al.
Histological Transformation to Gliosarcoma With Combined BRAF/MEK Inhibition in BRAF V600E Mutated Glioblastoma, Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
BRAF v600E-Mutant Cancers Treated With Vemurafenib Alone or in Combination With Everolimus, Sorafenib, or Crizotinib or With Paclitaxel and Carboplatin (VEM-PLUS) Study, Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, et al.
Phase 1b Study of Combined Selinexor and Eribulin for the Treatment of Advanced Solid Tumors and Triple-Negative Breast Cancer, Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors, Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
A Real-Time Contouring Feedback Tool For Consensus-Based Contour Training, Christopher L Nelson, Callistus Nguyen, Raymond Fang, et al.